Showing results (681-690 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|July 29, 2021
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 ReceptorSajjan Rajpoot, Tomokazu Ohishi, Ashutosh Kumar, et al.Drugs in R&D|June 20, 2022
Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After LaunchAngela Genge, Benjamin Rix Brooks, Björn Oskarsson, et al.Drugs in R&D|June 4, 2017
Comparison of Generic Drug Reviews for Marketing Authorization between Japan and CanadaRyosuke Kuribayashi, Scott AppletonDrugs in R&D|February 6, 2022
NLRP3 Inhibitor Tranilast Attenuates Gestational Diabetes Mellitus in a Genetic Mouse ModelJing Cao, Qian PengDrugs in R&D|February 12, 2022
Safety, Pharmacokinetic, and Pharmacodynamic Study of a Sublingual Formula for the Treatment of Vasovagal SyncopePaul Hutson, Regis Guieu, Jean-Claude Deharo, et al.Drugs in R&D|October 25, 2021
Pharmacokinetics of the Melanocortin Type 1 Receptor Agonist PL8177 After Subcutaneous AdministrationJohn Dodd, Robert Jordan, Marie Makhlina, et al.Drugs in R&D|April 5, 2022
Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney DiseaseLiangying Gan, Panpan Xie, Yan Tan, et al.Drugs in R&D|November 27, 2023
Drug-Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated MetabolismNicola Ferri, Sara De Martin, James Stuart, et al.Drugs in R&D|September 12, 2023
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting SystemDehua Zhao, Xiaoqing Long, Jiping Zhou, et al.Drugs in R&D|September 26, 2023
Effect of Tucatinib on Cardiac Repolarization in Healthy VolunteersAriel R Topletz-Erickson, JoAl G Mayor, Hsu-Tai Liu, et al.Pageof 89